Xenetic Biosciences (XBIO) Q1 2024 Annual Earnings
XBIO·Reported May 9, 2024·Before market open
Xenetic Biosciences reported Q1 2024 revenue of $510.8K, missed analyst consensus of $650.0K by $139.2K. Diluted EPS came in at $-0.78, beat the $-0.79 consensus by $0.01.
Revenue
$510.8Kmissed by $139.2K
Consensus: $650.0KDiluted EPS
$-0.78beat by $0.01
Consensus: $-0.79
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Xenetic Biosciences's Q1 2024 earnings report.
Xenetic Biosciences (XBIO) reported Q1 2024 earnings on May 9, 2024 before market open.
Xenetic Biosciences reported revenue of $510.8K and diluted EPS of $-0.78 for Q1 2024.
Revenue missed the consensus estimate of $650.0K by $139.2K. EPS beat the consensus estimate of $-0.79 by $0.01.
You can read the 10-K/A periodic report (0001683168-24-002740) directly on SEC EDGAR. The filing index links above go to sec.gov.